Suppr超能文献

罕见的同步多发早期肺腺癌伴MET外显子14跳跃、PIK3CA和KRAS突变:一例报告

Unusual Synchronous Multiple Primary Early-Stage Lung Adenocarcinoma with Concomitant MET Exon 14 Skipping, PIK3CA and KRAS Mutations: A Case Report.

作者信息

Zhang Yongjing, Gao Qiqi

机构信息

Department of Pathology, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.

出版信息

Case Rep Oncol. 2024 Aug 7;17(1):874-881. doi: 10.1159/000540355. eCollection 2024 Jan-Dec.

Abstract

INSTRUCTION

Synchronous multiple primary lung cancer (sMPLC) constitutes a distinct subtype of NSCLC, where accurate diagnosis and prognostic evaluation remain challenging.

CASE PRESENTATION

The case involves a 70-year-old male patient admitted to the hospital due to bilateral pulmonary nodules. The patient underwent staged resection. Molecular pathological examination revealed that tumor A harbored concurrent mutations in MET exon 14 skipping and PIK3CA (p.E545K), while tumor B exhibited a KRAS exon 2 (p.G12S/D) mutation. Postoperatively, the patient demonstrated a favorable recovery, with no evidence of recurrence for 1 year.

CONCLUSION

This study presents a case of sMPLC in early-stage lung cancer, illustrating the genetic heterogeneity in early-stage lung adenocarcinoma and underscoring the significance of precise evaluation of sMPLC and intrapulmonary metastases.

摘要

说明

同步性多原发性肺癌(sMPLC)是NSCLC的一种独特亚型,准确诊断和预后评估仍具有挑战性。

病例介绍

该病例为一名70岁男性患者,因双侧肺结节入院。患者接受了分期切除。分子病理检查显示,肿瘤A存在MET外显子14跳跃和PIK3CA(p.E545K)的同时突变,而肿瘤B表现出KRAS外显子2(p.G12S/D)突变。术后,患者恢复良好,1年内无复发迹象。

结论

本研究报告了一例早期肺癌中的sMPLC病例,阐明了早期肺腺癌的基因异质性,并强调了精确评估sMPLC和肺内转移的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4fb/11324270/4422736ef46a/cro-2024-0017-0001-540355_F01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验